PB
The startup provides chemically defined cell culture media and supplements that enhance cell growth performance beyond traditional serum and Essential 8. This offering addresses issues of batch-to-batch variability, contamination risks, and high costs associated with serum, facilitating the advancement of cellular-based therapies in clinical trials and research.
Updated 3 months ago
Funding
$840K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup provides chemically defined cell culture media and supplements that enhance cell growth performance beyond traditional serum and Essential 8. This offering addresses issues of batch-to-batch variability, contamination risks, and high costs associated with serum, facilitating the advancement of cellular-based therapies in clinical trials and research.